COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 1515: Articles 15141-15150  | Next

Introduction and transmission of SARS-CoV-2 B.1.1.7 in Denmark
Michaelsen, T. Y., Bennedbaek, M., Christiansen, L. E., Jorgensen, M. S. F., Moller, C. H., Sorensen, E. A., Knutsson, S., Brandt, J., Jensen, T. B. N., Chiche-Lapierre, C., Collados, E. F., Sorensen, T., Petersen, C., Le-Quy, V., Sereika, M., Hansen, F. T., Rasmussen, M., Fonager, J., Karst, S. M., Marvig, R. L., Stegger, M., Sieber, R., Skov, R. L., Legarth, R., Krause, T. G., Fomsgaard, A., Danish Covid-19 Genome Consortium, , Albertsen, M.
10.1101/2021.06.04.21258333 — Posted: 2021-06-07
Ecological Analysis of the Temporal Trends in the Association of Social Vulnerability and Race/Ethnicity with County-Level COVID-19 Incidence and Outcomes in the United States
Islam, S., Nayak, A., Hu, Y., Mehta, A., Dieppa, K., Almuwaqqat, Z., Ko, Y.-A., Patel, S. A., Goyal, A., Sullivan, S., Lewis, T. T., Vaccarino, V., Morris, A., Quyyumi, A. A.
10.1101/2021.06.04.21258355 — Posted: 2021-06-07
Early epidemiological signatures of novel SARS-CoV-2 variants: establishment of B.1.617.2 in England
Challen, R., Dyson, L., Overton, C., Guzman-Rincon, L., Hill, E., Stage, H., Brooks-Pollock, E., Pellis, L., Scarabel, F., Pascall, D. J., Blomquist, P., Tildesley, M. J., Williamson, D., Siegert, S., Xiong, X., Youngman, B., Consortium, J., Read, J. M., Gog, J. R., Keeling, M. J., Danon, L.
10.1101/2021.06.05.21258365 — Posted: 2021-06-07
Factors associated with excess all-cause mortality in the first wave of COVID-19 pandemic in the UK: a time-series analysis using the Clinical Practice Research Datalink
Strongman, H., Carreira, H., De Stavola, B. L., Bhaskaran, K., Leon, D. A.
10.1101/2021.06.04.21258344 — Posted: 2021-06-07
SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021
Sarwar, M. B., Yasir, M., Alikhan, N.-F., Afzal, N., de Oliveria Martins, L., Le Viet, T., Trotter, A. J., Prosolek, S. J., Kay, G. L., Foster-Nyarko, E., Rudder, S., Baker, D. J., Tul-Muntaha, S., Roman, M., Webber, M. A., Shafiq, A., Shabir, B., Akram, J., Page, A. J., Jahan, S.
10.1101/2021.06.04.21258352 — Posted: 2021-06-07
The Effect of Pandemic Prevalence on the Reported Efficacy of SARS-CoV-2 Vaccine Candidates: A Systematic Review and Meta-analysis
Sharma, R., Anand, A.
10.1101/2021.06.05.21258394 — Posted: 2021-06-07
SARS-CoV-2 Seroprevalence Among Firefighters in Los Angeles, California
Mulligan, K., Berg, A. H., Eckstein, M., Hori, A., Rodriguez, A., Toubat, O., Sood, N.
10.1101/2021.06.03.21258299 — Posted: 2021-06-07
The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trials
Wafa, I. A., Pratama, N. R., Budi, D. S., Sutanto, H., Rosyid, A. N., Wungu, C. D. K.
10.1101/2021.06.04.21258343 — Posted: 2021-06-07
Highly sensitive scent-detection of COVID-19 patients in vivo by trained dogs
Vesga, O., Agudelo, M., Valencia-Jaramillo, A. F., Mira-Montoya, A., Ossa-Ospina, I. F., Ocampo, E., Ciuoderis, K., Perez, L., Cardona, A., Aguilar, Y., Agudelo, Y., Hernandez-Ortiz, J. P., Osorio, J. E.
10.1101/2021.05.30.21257913 — Posted: 2021-06-07
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study
Soeorg, H., Jogi, P., Naaber, P., Ottas, A., Toompere, K., Lutsar, I.
10.1101/2021.06.06.21258406 — Posted: 2021-06-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).